ABOUT US
Founded in 2022, Bulmore Consulting has become a trusted partner in the pharmaceutical industry, specializing in Strategic Thought Leadership Advisement, Scientific Content Creation, and Medical Writing. Our expertise spans gene and drug delivery, synthetic biology, and regulatory compliance, and we have had the privilege of working with innovative teams in leading pharmaceutical companies. We're passionate about transforming our clients' visions into impactful narratives and strategic successes.​We invite new clients seeking to make a significant impact in healthcare to join us in shaping the future of medicine through strategic insight and expert guidance.
OUR TEAM
Our team comprises seasoned experts with diverse backgrounds in pharmaceuticals, biotechnology, and strategic communications, united by a passion for advancing pharmaceutical innovation. Each member brings a unique blend of scientific acumen and industry insight, ensuring our clients receive unparalleled expertise and guidance.
Marie Beitelshees, PhD
Managing Partner, Co-Founder
Marie Beitelshees, PhD, a managing partner at Bulmore Consulting, brings nearly a decade of expertise in gene and drug delivery, coupled with a specialized focus in nonclinical medical writing. Her extensive experience in technical writing has played a pivotal role in articulating complex scientific concepts into clear, impactful narratives. Marie's leadership and understanding of the pharmaceutical landscape are instrumental in steering Bulmore towards its mission of elevating clients as industry thought leaders and driving innovation in healthcare
Andrew Hill, PhD
Managing Partner, Co-Founder
Andrew Hill, Ph.D., is an expert in synthetic biology with an academic background in Chemical Engineering, now serving as a Managing Partner and Co-founder at Bulmore Consulting. His experience includes leading innovative projects in biotechnology such as his research in synthetic biology to engineer yeast for biochemical production and protein engineering as well as in vaccine development. Andrew has publication multiple influential papers in prestigious journals such as Nature Biotechnology, Nature Communications, PNAS, Science Advances, and Trends in Biotechnology. At Bulmore Consulting, he applies his expertise to providing strategic insights and technical writing, playing a crucial role in developing a thought leadership strategy that integrates scientific advancements with practical applications in the industry.